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aggressive therapies such as complex devices or ultrafiltration, as well as enabling 
an enriched end of life experience for those beyond such therapies. Enabling end 
stage patients to die in their location of choice would also release considerable 
resources at the same time.
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Objectives: We wanted to compare the patient satisfaction and compliance 
between a hospital with a trained clinical psychologist, acting as a mediator 
between physicians and patients and a hospital without one. MethOds: The 
comparison was done between two identical cardiac hospitals, which belong 
to the same network of cardiac facilities, for a period of six months. At each 
hospital, 200 patients were included. The patient characteristics, numbers and 
patient flow were comparable; the facilities were identical as level of comfort 
and staff training. To measure the patient satisfaction we used a questionnaire. 
The level of attendance of control visits after discharge we measured with the 
hospital registry. How many of the 200 patients stick to the discharge therapy 
after 3 and after 6 months after discharge, we measured with the out-patient cen-
tre registry and by telephone interviews. Results: In each hospital 200 patients 
were included and followed-up. For the hospital without clinical psychologist, 
patient satisfaction was 79% excellent marks (n= 158), control visits attendance 
was 42% (n= 84), patient compliance was 72% (n= 144) on the 3rd and 65% (n= 130) 
on the 6th month after discharge. For the hospital with a clinical psychologist, 
patient satisfaction was 97% excellent marks (n= 194), control visits attendance 
was 78% (n= 156), patient compliance was 96% (n= 192) on the 3rd and 89% (n= 178) 
on the 6th month after discharge. With the help of a trained clinical psychologist, 
we witnessed the following differences: 18% improvement in patient satisfac-
tion, 36% better attendance to control visits, 24% more compliant patients for 
both the 3rd and 6th month after discharge. cOnclusiOns: Trained clinical 
psychologists may play the role of a mediator and close the communication gap 
between physicians and patients and lead to improved patient satisfaction and 
compliance.
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Objectives: We wanted to establish the gap between physicians’ and patients’ 
understanding of patient needs in a hospital setting. MethOds: The study was 
run in the four of the Bulgarian Cardiac Institute clinics. We used questionnaires 
and within a period of two months, first we asked 30 physicians and 50 patients 
about what patient needs are according to their understanding. Based on the 
answers we defined 10 categories for each of the two groups. Then we asked 143 
physicians and 500 patients to define which category is most and least important 
for them by using the Maximum Difference Scaling technique. Results: Courtesy, 
after discharge recommendations and information about the discharge drugs were 
the top three most important patient needs according to the patients. Life-saving 
activities, improvement of quality of life and improve the longevity were the top 
three most important patient needs according to the physicians. cOnclusiOns: 
There is a tremendous gap between patients’ and physicians’ perceptions of 
patient needs. It is very hard for the hospitals to increase patient satisfaction 
relying on medical services only. Further research is needed to find ways to close 
that gap.
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Objectives: Given ethnic variation in attitudes toward hypertension (Ford 2010; 
Lewis 2010), study objectives are to determine 1) patient preferences concerning med-
ication use as revealed by responses to Beliefs about Medicines Questionnaire (BMQ, 
Horne 1999) in an urban black population with hypertension (HTN) and 2) if these 
preferences were influenced by experiences with parents/friends HTN diagnoses.  
MethOds: After approval from Northeastern University’s Institutional Review 
Board, coded clinic appointment schedules were used to identify patients sched-
uled for routine HTN follow-up appointment at a Boston inner-city community 
health center. Researchers screened for eligibility (English speaking, black eth-
nicity, taking anti-hypertensive medication), described the study, and requested 
informed consent. Patients agreeing to participate and completing background 
questions and the hypertension-specific Beliefs about Medicines questionnaire 
(BMQ: 18 items, 5 levels, strongly agree-strongly disagree) received a $10 CVS-
provided gift card. Results: 189 patients were approached. 94 (49.7%) completed 
the questionnaire, 11.6% declined, and 38.6% didn’t meet criteria, e.g., didn’t speak 
English or had previously completed the BMQ. Patients averaged 55.6yo, 67% 
female. Overall BMQ factor scores were: Specific Necessity (SN), 3.41 ±0.83; Specific 
Concerns (SC), 2.82 ±0.8; General Overuse (GO), 2.98 ±0.74 and General Harm (GH), 
2.54 ±0.72. Patients whose parent had a stroke had higher SN (p= 0.038) and lower 
GH scores (p= 0.042) than patients without that prior experience. There was no dif-
ference in any factors as to whether parents or a friend did/didn’t have hyperten-
sion and whether a friend did/didn’t have a stroke. SC were lower in patients with 
higher educational level (p= 0.002). No statistical associations occurred between 
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Objectives: While the independent influence of metabolic and cardiovascular 
diseases on either quality of life (QoL) or survival is well studied, the evidence on 
the combined burden in terms of quality adjusted life years (QALYs) is rather weak. 
Previous burden of disease studies mostly combined cross-sectional QoL data 
with mortality statistics from other data sources. However, due to strong model 
assumptions these studies might be limited in validity and accuracy. The goal of 
this study was to analyze the intermediate burden of diabetes in patients with 
previous myocardial infarction in terms of QALYs lost, by introducing a method 
capable to exploit primary longitudinal data sources of population-based stud-
ies. MethOds: Data for this analysis were taken from the KORA-Acute Myocardial 
Infarction (AMI) Registry. QoL (Euro-Qol-5D-index, German tariff) of a subset of 
patients known to be alive was assessed through postal surveys in 2006 (n= 1022) 
and subsequently in 2011 (n= 716). Mortality was tracked by the routine surveil-
lance system of the AMI Registry. QALYs gained were calculated assuming a 
linear QoL change from baseline to follow-up. QoL trajectories of non-respond-
ers at follow-up and patients who died before follow-up were approximated by 
multiple imputation methods using the baseline QoL and covariate structure. 
Ordinary least square regression models were performed to quantify the QALYs 
and life years (LYs) lost over the mean observation time. Results: Over a mean 
observation time of 4 years, patients with diabetes lost 0.14 LYs (3.75 vs. 3.89, 
p< 0.01) and 0.36 QALYs (2.96 vs. 3.33, p< 0.01) more than patients without diabe-
tes. The QALY-gap was greatest for diabetic patients taking insulin (-0.66, p< 0.01). 
Sensitivity analyses showed that models were robust concerning model assump-
tions. cOnclusiOns: The intermediate burden of diabetes for patients with CVD 
is substantial. Using individual-level data from population-based follow-up of 
studies is a valuable methodological extension to accurately quantify the burden 
of chronic conditions.
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Objectives: A secondary analysis was carried out to test if differences existed in 
reported treatment satisfaction between non-valvular atrial fibrillation patients 
(NVAF) treated with vitamin K antagonist (VKA) anticoagulants and new oral anti-
coagulants (NOAC). MethOds: A sample of 1318 patients was recruited at random 
in the FANTASIIA study, between June 2013 and March 2014, from which 77% were 
using VKA and 23% NOAC at least 6 months before inclusion. The specific treatment 
satisfaction instrument SAFUCA was used to test differences between groups. The 
SAFUCA questionnaire is composed by 7 dimensions and overall score, measured 
in a 0 (least satisfied), 100 (most satisfied) scale. Guyatt’s d was used to estimate 
effect size. Results: Mean age was 73.8 (SD= 9.4) years, and 42.5% were women. 
Patients using NOACs attained statistically significant higher values in the overall 
score and in all SAFUCA dimensions. Overall score effect size (NOAC vs VKA) was 
medium-small (79.91 vs 73.22, d= 0.43, p< 0.001). Small to large effect sizes were 
also found by dimension: Effectiveness (77.63 vs 72.70, d= 0.33, p< 0.01), Ease and 
Convenience (80.99 vs 73.72, d= 0.49, p< 0.001), INR Controls (62.35 vs 57.66, d= 0.32, 
p< 0.01), Impact on Daily Activities (90.08 vs 81.97, d= 0.55, p< 0.001), Medication 
Undesired Effects (86.20 vs 79.21, d= 0.47, p< 0.001), Satisfaction with Medical Care 
(80.30 vs 69.38, d= 0.74, p< 0.001), and Overall Satisfaction (80.30 vs 69.38, d= 0.74, 
p< 0.001). cOnclusiOns: SAFUCA questionnaire was able to detect satisfaction 
differences between NVAF patients treated with NOAC and those treated with VKA, 
presenting medium effect size in most dimensions. This new evidences offer addi-
tional support to the questionnaire validity.
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Objectives: Unplanned patient admissions to hospital with heart failure (HF) are 
on the increase due to an ageing population and increasing survival post coronary 
disease. Pre-discharge mortality is high, predictable and often occurs after many 
days stay for many patients and often without palliative care involvement, not 
aligned with guidance. MethOds: We audited palliative care input to HF patients 
admitted to our hospital as the predominant condition and subsequently passing 
away, both before and after an awareness campaign, publishing barriers to end 
of life dialogues between patient and clinicians, demonstrating the early use of 
a Get With The Guidelines (GWTG) risk assessment tool to predict mortality and 
introduction of a daily HF nursing team service. Results: In 2009, amongst 57 HF 
patients the average time to death was 17.8 days, only 7% received any palliative 
input before death. The time to death in these patients correlated positively with the 
(GWTG) predictive score indicating that these deaths could have been anticipated 
and appropriate palliative involvement triggered. Data from 2010 to 2013 following 
these interventions (n= 99) showed a marked improvement with 44% of patients 
having palliative input before death. The average time to death in this group was 
comparable at 17.22 days. cOnclusiOns: The care of HF patients and their families 
can be greatly improved with early mortality prediction, sensitive dialogues, routine 
involvement of HF teams both to enhance survival for patients who will benefit from 
